Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW
3,415.00
-70.00 (-2.01%)
Apr 30, 2026, 3:30 PM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Manufacturing and Selling in Vitro Diagnostic Kits | | | 348.64B | 1.03T | 505.11B | 121.80B | 43.06B | | | |
Manufacturing and Selling in Vitro Diagnostic Kits Growth | | | -66.28% | 104.68% | 314.71% | 182.86% | 7.01% | | | |
| | | 348.64B | 1.03T | 505.11B | 121.80B | 43.06B | | | |
| | | -66.28% | 104.68% | 314.71% | 182.86% | 7.01% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 1.22B | 758.78M | 6.70B | 12.45B | 27.93B | | | |
| | | 61.13% | -88.68% | -46.18% | -55.42% | -6.76% | | | |
| | | 4.93M | 162.12B | 40.57B | 826.38M | 1.10B | | | |
| | | -100.00% | 299.59% | 4809.64% | -25.01% | 50.91% | | | |
| | | 331.35B | 813.03B | 446.54B | 79.37B | 749.25M | | | |
| | | -59.24% | 82.07% | 462.64% | 10492.76% | -68.14% | | | |
| | | 37.25M | 107.31M | 1.51B | 1.40B | 3.60B | | | |
| | | -65.28% | -92.89% | 7.56% | -61.04% | 7.23% | | | |
| | | 13.72B | 30.37B | 30.41B | 18.28B | 9.27B | | | |
| | | -54.83% | -0.16% | 66.40% | 97.24% | 114.53% | | | |
| | | 346.33B | 1.01T | 525.74B | 112.32B | 42.65B | | | |
| | | -65.59% | 91.42% | 368.06% | 163.39% | 4.75% | | | |
Source: S&P Global Market Intelligence.